RJW & Partners consolidates senior level expertise with latest appointment
Publication date: 12 August 2010
Author: Limewash Media & Design
Tagged with: Natalie Shalet, Neil Johnson, RJW & Partners
Pricing and market access consultants to the pharmaceutical and medical device industries, RJW & Partners, are delighted to announce the appointment of Natalie Shalet as Senior Consultant, strengthening the pricing and market access capability within the firm.
Natalie Shalet
Natalie has over 10 years experience in the pharmaceutical and consulting industry and brings a broad knowledge of strategic pricing and market access consulting, business development, finance and clinical trial management to the team at RJW & Partners. She joins from Kantar Health (formerly MattsonJack), where as Director of Pricing and Market Access, Natalie developed new business and delivered project work for global pharmaceutical clients working in a range of therapy areas including, oncology, cardiovascular, diabetes, cholesterol management, bone marrow transplantation and pain.
Natalie began her industry career in clinical research at Theradex before moving into corporate finance and deal evaluation (mergers and acquisitions, IPO due diligence) in the Life Sciences division at WestLB Panmure. From there she moved to IMS Health to work as a Senior Consultant in client analysis and engagement, developing new ways of tracking launch progress through management dashboards for pharmaceutical clients, and identifying better ways to leverage internal information. Natalie then moved to oncology consulting at IMS where she was Business Development Manager, EMEA.
Natalie holds a BSc in molecular cell biology and an MSc in oncology from the University of Nottingham. She is fluent in French.
Neil Johnson, one of the founding Directors of RJW & Partners said: “We are delighted to welcome Natalie to the team. Her therapeutic area expertise is coupled with solid consulting experience and she has a proven commitment to delivering high quality strategic insights to clients. Natalie will be a considerable asset to our business delivery and development”.
RJW & Partners offer a complete suite of services spanning every stage of the product lifecycle including: pricing and market access strategy development, support planning and audit, global and affiliate strategy implementation, the evaluation of new in or out-licensing opportunities and organisational development and improvement. At the core of each assignment is the wish to make a meaningful and commercially tangible contribution to the development of the client’s business.
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Daiichi Sankyo and the National Cancer Center form comprehensive research alliance (22 May 2012)
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- FDA approves new labeling for ISENTRESS® (raltegravir) (21 May 2012)
- Capital increase in Lundbeck as a result of employee warrant programme (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content